Cargando...
Belimumab in Systemic Lupus Erythematosus
Belimumab is the only approved biological agent for the treatment of systemic lupus erythematosus (SLE). It is a fully humanized IgG1γ monoclonal antibody directed against soluble B lymphocyte stimulator (BLyS). It is indicated as an add-on therapy for the treatment of adult patients with active, au...
Gardado en:
| Publicado en: | Indian J Dermatol |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029243/ https://ncbi.nlm.nih.gov/pubmed/27688447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.190107 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|